Edesa Biotech announces 1-for-7 reverse share split effective October 11, 2023

Edesa Biotech, Inc.

Reverse split reduces outstanding shares from ~21.5M to ~3.07M; no change in proportional ownership.
No fractional shares issued; fractions rounding per British Columbia law.
Adjustments made to equity awards and warrants exercise prices and shares.
Shareholder approval not required under British Columbia corporate law.
Common shares continue trading under symbol EDSA with new CUSIP 27966L306.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.